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https://doi.org/10.1016/j.stemcr.2019.05.024SUMMARYIn vitro surrogatemodels of human cardiac tissue hold great promise in diseasemodeling, cardiotoxicity testing, and future applications in
regenerative medicine. However, the generation of engineered human cardiac constructs with tissue-like functionality is currently
thwarted by difficulties in achieving efficient maturation at the cellular and/or tissular level. Here, we report on the design and imple-
mentation of a platform for the production of engineered cardiac macrotissues from human pluripotent stem cells (PSCs), which we
term ‘‘CardioSlice.’’ PSC-derived cardiomyocytes, together with human fibroblasts, are seeded into large 3D porous scaffolds and cultured
using a parallelized perfusion bioreactor with custom-made culture chambers. Continuous electrical stimulation for 2 weeks promotes
cardiomyocyte alignment and synchronization, and the emergence of cardiac tissue-like properties. These include electrocardiogram-
like signals that can be readilymeasured on the surface of CardioSlice constructs, and a response to proarrhythmic drugs that is predictive
of their effect in human patients.INTRODUCTION
Cardiac tissue engineering aims at producing constructs
with structural, physiological, and functional properties
resembling human native cardiac tissue. Ultimately, such
in vitro models will find applications in disease modeling,
drug screening, and toxicology, and replacing or regenerat-
ing damaged heart tissue. The structural organization of
the cardiac tissue is complex, comprising a vast array of
diverse cell types (including fibroblasts, cardiac myocytes,
and smooth muscle, pacemaker, and endothelial cells), ar-
ranged in a precise and stereotypical architecture to ensure
that the critical function of pumping blood throughout the
body is maintained (Chien et al., 2008). Efficient blood
pumping requires the 5 billion cardiomyocytes that
make up an average human adult heart contracting and re-
laxing in a coordinated and timely order. Multiscale struc-
tural features characteristic of the heart’s intracellular and
intercellular organization enable the necessary coordina-
tion for the entire heart muscle to form a functional syncy-
tium (Hunter et al., 2003). This results in electrochemical
processes of such magnitude that generate voltage poten-Stem
This is an open access article under the Ctials of 1 mV, easily recorded on the body surface. That
the shape of these voltage potential waves (electrocardio-
gram [ECG]) is a reliable indicator of cardiac performance,
used on a routine basis in clinical cardiology for over a cen-
tury (Fermini and Fossa, 2003), clearly attests to the inti-
mate dependence of structure and function in the heart.
Due to the high dependence found between cardiacmus-
cle structural organization and its function, it has been hy-
pothesized that growing cardiac constructs in engineering
systems mimicking relevant physicochemical stimuli
found in vivo would be advantageous to achieve tissue-
like properties (Fleischer et al., 2017). In the last years, tis-
sue-engineering methods have significantly advanced in
generating functional 3D cardiac constructs (Radisic
et al., 2004a; Shimizu et al., 2002; Zimmermann et al.,
2002). A key issue that has deserved much attention in
this field is the degree of cardiomyocyte maturation
achieved within the engineered cardiac constructs (re-
viewed in Parsa et al., 2016). This issue is particularly
important when using cardiomyocytes derived from
pluripotent stem cells (PSCs), which are typically imma-
ture, fetal-like under standard two-dimensional (2D)Cell Reports j Vol. 13 j 207–220 j July 9, 2019 j ª 2019 The Authors. 207
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
(legend on next page)
208 Stem Cell Reports j Vol. 13 j 207–220 j July 9, 2019
differentiation conditions (Feric and Radisic, 2016). Hu-
man engineered cardiac constructs developed thus far reca-
pitulate some of the structural complexity and electrome-
chanical functionality of the native myocardium, leading
to improved performance compared with standard 2D
in vitro cultures (Ma et al., 2015; Nunes et al., 2013; Schaaf
et al., 2011; Thavandiran et al., 2013). Exogenous stimuli
such as mechanical and electrical signals have been shown
to further improve the electrophysiological properties, the
cellular and ultrastructural organization, and the expres-
sion of cardiac-specific proteins of cardiac constructs (God-
ier-Furnemont et al., 2015; Radisic et al., 2004a; Tandon
et al., 2009). These strategies have resulted in microengi-
neered models of human cardiac muscle, which emerged
as promising platforms for preclinical toxicology and
drug screening assays (Amano et al., 2016; Hansen et al.,
2010; Mathur et al., 2015). However, microtissues are min-
imal units with some cardiac functionality, but are inher-
ently limited in size and cannot fully capture the
complexity of the native cardiac tissue structure (Kurokawa
and George, 2016). Unfortunately, the production of hu-
man macroscale tissues displaying in vivo-like complexity
and, therefore, tissue-like functionality, is still an unmet
challenge (Fleischer et al., 2017).
The design of tissue-engineering constructs on the
macroscale (greater than 300 mm in thickness) is met with
the challenge that effective mass transfer cannot rely on
passive diffusion alone (Lovett et al., 2009). This is critical
for cardiac tissue constructs due to the comparatively
high metabolic demand of cardiac muscle cells, which re-
quires a controlled microenvironment with the appro-
priate supply of oxygen and nutrients (Carrier et al.,
2002; Radisic et al., 2004b, 2008). Perfusion bioreactor sys-
tems pioneered in Vunjak-Novakovic’s laboratory have
proved to be valuable in the generation of thick cardiac tis-
sue constructs full of viable cells with aerobic metabolism
(Radisic et al., 2004b). Here, we have designed and imple-Figure 1. Parallelized Perfusion Bioreactor for the Generation of
(A) Scheme of the custom-made perfusion chamber and 3D modeling o
5 V. The chamber scheme depicts two stimulation electrodes (black), o
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in the geometry, positive and negative, respectively) and predicted e
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electrode. Interstitial flow of culture medium (red arrow) is routed th
(C) Voltage measurements in the perfusion chamber with electrical sti
by the model.
(D) Overall view of the parallel bioreactor system: medium reserv
perfusion chambers (5), gas exchanger (6), and peristaltic pump (7).
simultaneously.mented a platform to produce macrotissues of engineered
cardiac muscle from human PSCs, which we termed ‘‘Car-
dioSlice.’’ PSC-derived cardiomyocytes differentiated un-
der standard 2D conditions were seeded, together with hu-
man fibroblasts, into 3D porous scaffolds of 10 mm in
diameter and 1 mm in thickness. Constructs were cultured
for up to 14 days in a parallelized perfusion bioreactor
equipped with custom-made culture chambers endowed
with electrostimulation capabilities. The constructs ob-
tained developed into macroscopically contractile struc-
tures in which cardiomyocytes showed signs of increased
cell maturation compared with those cultured under 2D
conditions, and similar to those of microtissues. More
importantly, continuous electrical stimulation of the car-
diac macrotissues for 2 weeks promoted cardiomyocyte
alignment and synchronization, and the emergence of car-
diac tissue-like properties. These translated into sponta-
neous electrical activity that could be readily measured
on the surface of CardioSlice constructs as ECG-like signals,
and a response to proarrhythmic drugs that was predictive
of their effect in human patients.RESULTS
Development of a Parallelized Bioreactor for
Continuous Perfusion and Electrical Stimulation/
Recording of Cardiac Macroscale Constructs
To generate CardioSlice constructs, we designed a parallel-
ized perfusion bioreactor including electrical stimulation
(Figure 1). Our a priori design requirements included: (1)
suitability for the perfusion of macroscale constructs
(10 mm in diameter and 1–2 mm in thickness); (2) capa-
bility for in vivo-like electrical stimulation; (3) ability to pro-
duce interstitial flow with proper shear; (4) amenability to
parallelization for the simultaneous culture of multiple
constructs; and (5) on-line recording of the constructCardioSlice Constructs
f the electric field generated when applying a differential voltage of
ne at each side of the construct (pink), and a central gold electrode
askets (gray) hold the construct in place and direct the fluid (red)
l the electrical field. Electrode configuration (red and blue cylinders
lectric field and current density values are displayed both in 3D and
. Plots show electric field and current density values at the positions
(from x = 2.5 to x = 2.5).
ical stimulation. The cardiac construct (scaffold + cells; pink) is held
electrodes, and the yellow rectangle and dot represent the gold
rough the pores of the construct.
mulation. Measured electric field values match the values predicted
oir (1), luer manifold (2), de-bubblers (3), flow restrictors (4),
The bioreactor supports the culture of up to four cardiac constructs
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electrical activity. To address these requirements, we first
formulated an electric field model to determine the appro-
priate size and allocation of the stimulating electrodes
within the chamber (Figure 1A). We simulated the electric
field and current density generated by two graphite elec-
trodes (5mm in diameter) separated 1 cm apart and in con-
tact with culturemedium. Solving themodel resulted in an
electric field of around 400 V/m and a current density of
around 600 A/m2 in the center of the chamber, when a dif-
ferential voltage of 5 V was applied. Similar values were ob-
tained for the entire region intended for use to allocate the
cardiac construct containing cells, thusmaking this config-
uration suitable for cardiomyocyte stimulation in terms of
magnitude and uniformity according to the literature (Bar-
ash et al., 2010; Tandon et al., 2009). We then fabricated
custom-made perfusion chambers including electrodes
with the specifications included in the simulation (Fig-
ure 1B). Upon fabrication, we measured the voltage values
in the actual perfusion chamber to verify that the expected
stimuli were properly delivered (Figure 1C). Rectangular
pulses at 3 Hz of frequency, 2 ms of duration, and
increasing differential voltages from 1 to 5 V were applied
to the chamber. Electric potentials between stimulating
graphite electrodes and between each electrode and the
center of the chamber (gold electrode) were measured.
The intendedwaveformwas reliably applied for all voltages
tested. Moreover, when applying 5 V between graphite
electrodes, 2 Vweremeasured in the center of the chamber,
representing an electric field of 400 V/m, in agreement
with the values predicted by the model.
The shear stress to which cells would be exposed in the
perfusion bioreactor was calculated as previously described
(Radisic et al., 2008). The minimum flow rate needed for
efficiently perfusing cardiac macrotissues depends on the
overall mass balance of oxygen, and was estimated to be
0.1 mL/min for rat cardiac tissue constructs and 0.2 mL/
min for human cardiac tissues. Shear stress affecting the
cells within the scaffold was then calculated by taking
into account the flow rate, culture medium viscosity
(0.0078 dyn,s/cm2) (Bacabac et al., 2005), and the volume
(19.6 mm3), void fraction (0.94), and mean pore radius
(8.5 mm, Figure S1A) of the scaffold. Perfusion of culture
medium at 0.1 mL/min evoked a shear stress of around
0.7 dyn/cm2 while perfusion at 0.2 mL/min yielded a shear
stress of around 1.3 dyn/cm2. According to the literature,
the values selected for the perfusion flow rate are sufficient
to satisfy mass transport requirements associated with car-
diacmuscle tissue (Radisic et al., 2008), while the associated
shear stress values do not compromise cardiomyocyte func-
tionality and viability (Cheng et al., 2009; Radisic et al.,
2008; Shachar et al., 2012).
Next, the custom-made perfusion chambers including
electrical stimulation were installed in the parallelized210 Stem Cell Reports j Vol. 13 j 207–220 j July 9, 2019perfusion bioreactor (Figure 1D). Parallelization of the cul-
ture system allowed the production of multiple cardiac
macrotissues under the same physicochemical conditions
and from the same pool of cells. Fluidic restrictors were
installed (Rrestrictor 1013 >> Rmanifold 107) to ensure that
the flow was homogeneously distributed through all
branches. Finally, on-line recording of the electrophysio-
logical activity of cardiac tissue constructs was carried out
using the two graphite electrodes used for electrical stimu-
lation (one acting as the source and the other one as the
reference), and a gold electrode as an internal reference
(Figures 1B and S1B). Recorded signals were amplified and
noise-filtered to obtain the electrical activity of the
constructs.
Structural Signs of Cell and Tissue Maturation in
CardioSlice Constructs
To create human cardiac macrotissues, we differentiated
cardiomyocytes from human induced PSCs (hiPSCs)
following a robust and reproducible protocol based on
modulation of Wnt/b-catenin signaling with small-mole-
cule inhibitors (Lian et al., 2013). hiPSCs differentiated in
this way formed contracting monolayers comprising
high percentages of cardiomyocytes, as defined by coex-
pression of cardiac troponin I (cTnI) and myosin heavy
chain (MHC) proteins (71.6% ± 5.3% cTnI+/MHC+ cells)
after 20 days of differentiation (Figure S2). In preliminary
studies, we determined that fully differentiated cardio-
myocytes (i.e., after 20 days of differentiation from
hiPSCs), but not undifferentiated hiPSCs or early
committed mesoderm progenitors (as defined by the
expression of T/Brachyury), could be cultured within
the porous scaffolds under continuous perfusion for up
to 21 days while maintaining a differentiated phenotype
(data not shown). We also verified that addition of fibro-
blasts to iPSC-derived cardiomyocytes improved the
reproducibility of obtaining viable cardiac constructs, in
agreement with previous studies (Amano et al., 2016;
Liau et al., 2017; Tiburcy et al., 2017). Based on those pre-
liminary results, for the present studies we used a
mixture of hiPSC-derived cardiomyocytes and human
dermal primary fibroblasts seeded in a 7:1 ratio. We chose
a commercial, clinical-grade porous scaffold made up of
collagen and elastin to culture the cells, on account of
its biocompatibility and myocardium-like pore size
and stiffness (Figure S1A). A total of 5 million cells
were seeded into the scaffolds using an on-purpose de-
signed perfusion loop (see details in Experimental Pro-
cedures and Figure S1B).
In a first set of experiments, we tested the effects of
electrical stimulation on human cardiac macrotissues. For
this purpose, constructs were introduced into perfusion
chambers and randomly assigned to the control group
Figure 2. Morphology and Ultrastructural Organization of Human Cardiac Macrotissues
(A) Representative cross-sections of cardiac constructs after 14 days of culture without (Control) or with electrical stimulation
(CardioSlice). hiPSC-derived cardiomyocytes positive for cardiac troponin (cTnT; green) and phalloidin (Ph; red) were detected in the
scaffold. Nuclei were stained with 40,6-diamidino-2-phenylindole (DAPI; blue). Cardiac macrotissues were analyzed by Second Harmonic
Generation for the detection of collagen (Col; violet). Scale bars, 500 mm (left); higher magnifications (left to right), 100 mm, 50 mm, and
10 mm, respectively.
(B) Standard 2D culture of hiPSC-derived cardiomyocytes in monolayer. Cardiomyocytes were positive for cardiac troponin (cTnT; green)
and phalloidin (Ph; red). Scale bar, 50 mm.
(C) Ultrastructural analysis of hiPSC-derived cardiac macrotissues. Representative transmission electron microscopy images of cardiac
macrotissues after 7 and 14 days of culture. Scale bars, 1 mm (bundles) and 0.5 mm (sarcomere width and cell junctions).
(D) Morphometric analysis showing sarcomere width. Each individual sarcomere width is represented as a dot in the graph and at least 200
sarcomeres per independent experiment were measured in three independent experiments (***p < 0.001, N = 3, nR 200 per group; Mann-
Whitney U test). Data are expressed as mean ± standard deviation (SD).(only perfusion) or the CardioSlice group (perfusion and
electrical stimulation), and maintained in culture for up
to 14 days. Human cardiac macrotissues exhibited cardio-
myocytes and fibroblasts distributed throughout the
scaffold thickness (Figure S3A). Cardiomyocytes stronglyexpressed cardiac contractile proteins, including cardiac
troponin T (cTnT) and a-sarcomeric actin (Figure 2A),
with signs of increased cardiomyocyte maturation
compared with cells cultured for the same time period un-
der conventional 2D conditions (Figure 2B). No differencesStem Cell Reports j Vol. 13 j 207–220 j July 9, 2019 211
Figure 3. Functional Assessment of Human Cardiac Macrotissues
(A) Top-view images of human cardiac macrotissues after 7 and 14 days of culture, both without (Control) or with (CardioSlice) electrical
stimulation. Scale bars, 2.5 mm.
(B) Contraction amplitude analysis of Control and CardioSlice constructs after 7 and 14 days of culture. Area oscillation is represented over
time.
(legend continued on next page)
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in cardiomyocyte proliferation or viability, as judged by the
number of Ki67-positive cardiomyocytes and the number
of TUNEL-positive cardiomyocytes, respectively, were
found when comparing CardioSlice and control constructs
after 14 days of culture (Figures S3B and S3C). Cardiomyo-
cytes in CardioSlice constructs were mostly aligned along
the direction of electric field vector used for stimulation,
in contrast with the random distribution found in control
constructs (Figure 2A), a finding also observed in rat-
derived cardiacmacrotissues (Figure S4A). At the ultrastruc-
tural level, cardiomyocytes in CardioSlice constructs dis-
played a statistically significant increase in sarcomere
width compared with those in control constructs, after
both 7 and 14 days in culture (day 7: 0.70 ± 0.38 mm for
CardioSlice and 0.52 ± 0.29 mm for control; day 14:
0.83 ± 0.38 mm for CardioSlice and 0.64 ± 0.35 mm for con-
trol; p < 0.001) (Figures 2C and 2D), indicating a higher de-
gree ofmaturation.Moreover, after 14 days in culture,more
developed intercalated discs were detected in CardioSlice
than in control constructs (Figure 2C). This was again in
agreement with the improved ultrastructural signs of
cardiomyocyte maturation observed in rat-derived cardiac
macrotissues, where wider sarcomeres and better devel-
oped intercalated discs were present in electrostimulated
compared with control constructs (Figures S4B and S4C).
The expression level of key cardiac genes was measured
in control and CardioSlice constructs and compared with
those of cells cultured for equivalent periods of time under
conventional 2D conditions (Figure S3D). As expected,
maturity-related cardiac genes (MYH7, ACTC1, TNNT2,
MLC2V, GATA4, and GJA1) and genes encoding cardiac
ion channels (RYR2, SERCA2A, CACNA1C, SCNA5A,
KCNH2, and KCNQ1) were expressed under all conditions
analyzed. However, no conspicuous differences were noted
in cells cultured under either 2D or 3D conditions when
comparing control andCardioSlice constructs (Figure S3D).
Overall, the expression levels of maturity-related cardiac
genes and cardiac ion channels were more similar to those(C) Bar chart showing the percentage of fractional area change (FAC) f
n R 3 per group; Mann-Whitney U test).
(D) Maximum capture rate (MCR) of Control and CardioSlice constructs
n R 3 per group; Mann-Whitney U test).
(E) Representative velocity maps of beating human cardiac macrotiss
higher velocities, while blue colors and shorter arrows represent lowe
(F) Analysis of the alignment between beating direction of human
parameter <cos 2q> was used, with values close to 0 meaning rand
(average ± SD) (***p < 0.001, N = 4, n R 4 per group; Mann-Whitne
(G) Strain rate of representative macrotissues over time. The curve is o
per frame) over the whole construct at every time point. Positive
respectively.
(H) Strain rate per beat (average ± SD) (**p < 0.01, N = 4, n R 4 p
(contractions) were integrated over time and divided by the numberof fetal human heart than to those of adult ventricular tis-
sue, consistent with previous analyses of human iPSC-
derived cardiomyocytes (reviewed in Yang et al., 2014).
These results indicate that any differences observed in the
functionality of cardiac macrotissues should be attributed
to changes in the maturation of the multicellular structure
rather than to the maturation of its individual cellular
constituents.
Biomechanical Signs of Tissue Maturation in
CardioSlice Constructs
Upon harvesting, both control and CardioSlice constructs
displayed spontaneous beating, which was much more
apparent macroscopically in the case of CardioSlice con-
structs (Videos S1, S2, S3, and S4). We did not find differ-
ences in the spontaneous beating rate between CardioSlice
and control constructs, which wemonitored after 4, 7, and
14 days of culture, and ranged from 0.6 to 1.1 beats/s. Elec-
tric field stimulation had a direct impact on cell distribu-
tion within the CardioSlice constructs, as cells concen-
trated in the region were delimited by the stimulating
electrodes (Figure 3A). The amplitude of contraction,
determined by measuring the changes in the fractional
area during spontaneous beating, was significantly
higher in CardioSlice constructs compared with control
ones (day 7: 6.54% ± 0.94% for CardioSlice constructs
compared with 0.54% ± 0.09% for control constructs; day
14: 7.85% ± 0.75% for CardioSlice constructs compared
with 2.08% ± 0.12% for control constructs; p < 0.001), indi-
cating improved maturation of the electromechanical
coupling machinery (Figures 3B and 3C). Consistently,
CardioSlice constructs also exhibited significantly higher
values for the maximum capture rate (MCR) parameter
when compared with control samples. This was evident
after 14 days of culture: 4.28 ± 1.63 Hz in CardioSlice
constructs versus 2.43 ± 0.75 Hz in control constructs
(p < 0.001) (Figure 3D). The effects of continuous electric
stimulation were not specific to human cells, since similaror each cardiac macrotissue (average ± SEM) (***p < 0.001, NR 3,
after 7 and 14 days of culture (average ± SD) (***p < 0.001, NR 3,
ues after 14 days of culture. Red colors and longer arrows represent
r velocities. Scale bar, 2.5 mm.
cardiac macrotissues and direction of the electric field. The order
om distribution and values close to 1 meaning parallel alignment
y U test).
btained by integrating the local strain rate (e.g., local area change
and negative values correspond to contractions and relaxations,
er group; one-way ANOVA). The positive values of the strain rate
of beats.
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improvements in contractile behavior were obtained with
rat-derived cardiac constructs (Figures S4D–S4F).
Velocity maps generated with particle image velocimetry
demonstrated that the velocity in each contraction was
higher in CardioSlice constructs than in controls, corrobo-
rating their enhanced contractile performance (Figure 3E).
Directionality of contractions was calculated by deter-
mining the alignment of velocity vectors with respect to
the direction of the stimulating electric field, and expressed
by the order parameter <cos 2q> (Figure 3F). CardioSlice
constructs contracted parallel to the direction of the elec-
tric field applied during culture (<cos 2q> close to 1),
whereas control constructs displayed random distribution
of velocity vectors (<cos 2q> = 0). Regarding the contractile
strain generated in each contraction, CardioSlice con-
structs displayed higher strain rates compared with control
constructs (Figure 3G), with a significantly higher (p < 0.01)
average strain rate per beat (Figure 3H). Taken together,
these results demonstrate that paced electrical stimulation
of cardiac macrotissues over the 2 weeks of culture dramat-
ically enhances contractile performance, and suggest
improved maturation at the tissue level under these
conditions.
CardioSlice Constructs Generate ECG-like Signals
Human cardiac macrotissues produced a bioelectrical
signal that was a sum of the action potentials generated
by the individual cardiomyocytes constituting the
construct. Such signals could be registered on the surface
of constructs using the electrodes embedded within the
perfusion chamber (Figure 4A). In control constructs the re-
corded electrical signals were of low amplitude and long
duration, which is consistent with the incomplete syn-
chronization of contractions visualized across the macro-
tissue (Video S2). In contrast, CardioSlice constructs eli-
cited bioelectrical signals composed of narrow and steep
waveforms that include the QRS complexes and repolariz-
ing Twaves, remarkably similar to those of standard surfaceFigure 4. Electrocardiogram-like Signals Generated by Human Ca
(A) Representative electrocardiogram (ECG)-like signals (voltage re
(Control) and electrically stimulated (CardioSlice) human cardiac ma
complex and T wave over the averaged ECG-like beats (signals for 10
(B–D) Box plots showing the QRS complex duration (B), the QT interv
signals generated by human cardiac macrotissues. Each experimenta
sponding mean CardioSlice value. Box plot represents median, 25%, a
(***p < 0.001, N R 4, n R 4 per group; F test).
(E and F) Representative ECG-like signals recorded from CardioSlice
cubation, light-gray lines) treatments with isoproterenol (E) and carb
QRS complexes are indicated by arrows. Bar charts show the change
carbachol treatments. Data plotted show relative changes with respec
experiment (average ± SEM) (***p < 0.001, N = 3, n = 3 per group; M
filtered (zero-phase fourth-order Butterworth filter with cutoff frequeECG for human ventricularmyocardium (Figure 4A).More-
over, ECG-like signals recorded fromCardioSlice constructs
were of statistically significantly higher amplitude, shorter
QRS duration, and shorter QT interval than those of
control constructs (Figures 4B–4D). These results indicate
that cardiomyocytes within CardioSlice constructs are
electrically better coupled than within control constructs,
attaining the fast conduction velocity and improved
action potential propagation characteristic of a functional
syncytium.
Wenext testedwhether cardiomyocytes withinmacrotis-
sue constructs retained the ability to respond to positive
and negative inotropic factors. Similar to iPSC-derived
cardiomyocytes cultured under standard 2D conditions
and to control macrotissue constructs (data not shown),
CardioSlice constructs increased or decreased beating rate
upon treatment with isoproterenol or carbachol, respec-
tively (Figures 4E and 4F).
Prediction of Drug-Induced Cardiotoxicity Using
CardioSlice Constructs
To investigate the ability of human cardiac macrotissues to
predict drug-induced cardiotoxicity, we incubated macro-
tissues at day 14 of culture with sotalol, a human ether-a-
go-go (hERG) potassium channel blocker and adrenergic
antagonist. Upon 10 min of treatment, control cardiac
macrotissues showed no consistent alterations in the fre-
quency or morphology of ECG-like signals (Figures 5A
and S5A), making it difficult to determine any drug effect.
In contrast, CardioSlice constructs displayed a progressive
decrease in beating frequency, consistent with sotalol ac-
tion as adrenergic antagonist (Figure S5B). More impor-
tantly, we could detect features typical of arrhythmia,
such as ectopic QRS, prolongation of RR intervals, and reg-
ular blockades (Figure 5B). These features appeared progres-
sively, were more frequent over time of incubation with so-
talol, and coincided with abnormal prolongation of the QT
interval, which experienced increases greater than 20%rdiac Macrotissues during Spontaneous Beating
corded as a function of time). Left panel shows non-stimulated
crotissues during spontaneous beating. Right panel shows the QRS
min were considered).
al duration (C), and the amplitude of the QRS complex (D) from the
l pair (Control and CardioSlice) has been normalized by the corre-
nd 75%, and whiskers correspond to maximum and minimum values
constructs before (first minute, black lines) and after (10-min in-
achol (F). Time intervals between two consecutive R peaks (RR) of
of the beat rate (defined as 1/RR) induced by isoproterenol and
t to the mean beat rate value before treatment (baseline) for each
ann-Whitney U test). All ECG-like bioelectric signals were bandpass
ncy of 0.2 and 40 Hz, respectively).
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Figure 5. Effects of Sotalol on the ECG-
like Signal of CardioSlice Constructs
(A, B, and D) Representative ECG-like signals
for control (A) and CardioSlice (B and D)
constructs cultured for 14 days after treat-
ment with sotalol.
(A) ECG-like signals recorded from control
constructs upon 14 and 18 min of treatment
with sotalol.
(B) ECG-like signals recorded from Car-
dioSlice constructs upon 14 and 18 min of
treatment with sotalol. Prolongations in time
intervals between two consecutive R peaks
(RR) of QRS complex are represented by solid
points.
(C) QT interval prolongation in CardioSlice
constructs, estimated by signal averaging at
basal conditions and after 5 and 10 min of
incubation with sotalol. QT interval is shown
over the averaged ECG-like signals at basal
conditions by arrows. The QRS complex and T
wave are also shown. The smaller vertical
lines indicate the end of T wave. The effects
of sotalol on the ECG-like of control and
CardioSlice constructs were analyzed in
four independent experiments (Control N = 4,
n = 5; CardioSlice N = 4, n = 4).
(D) ECG-like signals for CardioSlice constructs upon 14, 18, and 23 min of treatment with sotalol. Inversion of ECG-like signals are
represented by asterisks. All ECG-like bioelectric signals were bandpass filtered (zero-phase fourth-order Butterworth filter with cutoff
frequency of 0.2 and 40 Hz, respectively).(Figure 5C). After prolonged incubation times with
sotalol, CardioSlice constructs displayed severe alterations
in ECG-like signals, with QRS complexes becoming
smaller, inverted, and even disappearing after 30 min of
drug treatment (Figure 5D). The observed electrophysiolog-
ical alterations translated, at the mechanical level, into
dyssynchronous contractile patterns in sotalol-treated
CardioSlice constructs (Figure S5B). Therefore, sotalol
impaired the electrical conduction within CardioSlice con-
structs and affected their contractile behavior, demon-
strating the proarrhythmic potential of the drug. On the
whole, these results indicate that CardioSlice constructs
are suitable in vitro models for prediction of drug-induced
cardiotoxicity.DISCUSSION
Environmental cues are key determinants of cardiomyo-
cyte phenotype and function, and regulate their capacity
to form functional tissue units. Despite recent advances,
in vitro generation of human heart tissue is still limited by
the existing tissue-engineering technologies, which are
not able to recapitulate the complex structure and function216 Stem Cell Reports j Vol. 13 j 207–220 j July 9, 2019of the humanmyocardium. Electrical stimulation, alone or
in combination with mechanical loading, has been widely
applied in tissue engineering to generate cardiac constructs
that recapitulate some aspects of the native physiology
(Godier-Furnemont et al., 2015; Nunes et al., 2013). Electri-
cal pacing has also been applied to the generation of hu-
man cardiac microtissues (Nunes et al., 2013; Ruan et al.,
2016; Thavandiran et al., 2013; Xiao et al., 2014). Such mi-
crotissues are usually fabricated by using cell-laden natural-
based hydrogels cast on posts (Fennema et al., 2013; Hin-
son et al., 2015; Huebsch et al., 2016; Kensah et al., 2013;
Ruan et al., 2016; Schaaf et al., 2011; Soong et al., 2012;
Thavandiran et al., 2013; Tiburcy et al., 2017; Turnbull
et al., 2014; Zhang et al., 2013) or around a wire template
(Nunes et al., 2013; Xiao et al., 2014). While some of those
constructs could be quite large in surface area, even larger
than ours (Nakane et al., 2017; Shadrin et al., 2017;
Tiburcy et al., 2017), their thickness was constrained by
the 300-mm limit of oxygen diffusion in passive culture
systems (Lovett et al., 2009). To overcome such size limita-
tion, the production of thicker cardiac constructs can
be then performed by medium perfusion bioreactors,
which are able to maintain cell viability over time (Radisic
et al., 2008). Perfusion bioreactors incorporating electrical
stimulationhave been previously applied for in vitro culture
ofmurine cardiomyocyte 3D tissue structures (Barash et al.,
2010; Kensah et al., 2011; Maidhof et al., 2012). However,
this research had been rarely transferred to human cardiac
tissue-engineering models (Ma et al., 2014; Tiburcy et al.,
2017) and not previously used to combine iPSC-derived
cells and 3D thick scaffolds with simultaneous perfusion
and electrical stimulation to develop macrotissues of
human cardiomyocytes. Herein, we have developed a par-
allelized bioreactor system equipped with electrodes to
electrically stimulate human iPSC-derived cardiomyocytes
during perfusion in culture.
Electrical stimulation has been proposed to be a require-
ment for the electrophysiological maturation of cardiac
constructs, favoring cardiomyocyte contractility, align-
ment, and organization within cardiac tissue constructs
(Nunes et al., 2013; Radisic et al., 2004a). In our case, after
14 days in culture, cardiomyocytes in CardioSlice con-
structs displayed small, but measurable, signs of increased
cell maturation compared with control constructs,
showing wider sarcomeres and more developed intercel-
lular unions (Figures 2C and 2D). Nevertheless, the expres-
sion levels ofmaturity-related cardiac genes and cardiac ion
channels indicated immature fetal-like cardiomyocyte
characteristics, still far from those of adult myocardium
(Figure S3D). Notably, however, continuous electrical stim-
ulation did have a profound effect on the properties of
CardioSlice constructs at the tissue level, resulting in
greatly improved electromechanical coupling. We believe
that the implications of these findings are important in
two respects: First, our findings illustrate a viable approach
to engineering humanmyocardial surrogates with value for
cardiac toxicity testing. In this respect, most previous
studies aimed at producing adult-like cardiac constructs
focused on increasing the degree of maturation of cardio-
myocytes (with only relative success to date: see Nunes
et al., 2013; Ronaldson-Bouchard et al., 2018; Ruan et al.,
2016; Tiburcy et al., 2017), while our findings highlight
the usefulness of promoting the maturation at the tissue
level, in a way that supersedes and does not strictly depend
on the maturation at the cellular level. Second, on a more
conceptual note, our findings provide experimental sup-
port for the appearance of emergent behaviors in the
context of a complex system (Gao et al., 2018) such as
myocardial tissue organization and function, where rela-
tively small changes in the properties of the system ele-
ments (cardiomyocytes) can lead to higher-order behaviors
at greater scales (tissue). In the case ofmyocardial tissue this
appears to be particularly relevant, probably because of the
system’s normal operation as a functional syncytium
(Hunter et al., 2003). Tissue-like maturation of CardioSlice
constructs resulted in contractions with an amplitude
6-fold higher than that of control constructs. Moreover,ECG-like signals elicited by CardioSlice constructs showed
a uniform and reproducible pattern of narrow, steep, and
well-defined QRS complexes that very much resembled
actual ECG heart recordings. In contrast with CardioSlice
constructs, the bioelectrical signals generated by control
constructs were highly heterogeneous, of comparatively
lower amplitude and longer duration of waveforms, indic-
ative of slowly conducting tissues.
By incorporating electrodes in our bioreactor chamber,
we were able to not only stimulate our constructs but also
provide the system with the capability of on-line moni-
toring of the electrophysiological behavior of thick cardiac
constructs in a non-destructive manner. As no standard
method exists for the assessment of electrophysiological
information from intact macroscale-sized heart tissue
(Tzatzalos et al., 2016), the technology developed here is
unique in this context. The bioelectrical signal obtained
in this way is extremely informative of the electrically
active cells within the construct and, most importantly,
of the intercellular coupling at themacro (whole construct)
scale, very similar to the case of surface ECG recordings in
humans.
Typically, safety of cardiac drugs is assessed bymeasuring
currents on hERG ion channels ectopically expressed in
non-cardiac cell lines (HEK293, CHO). These assays pro-
duce false positives and false negatives, as in the cases of
verapamil and alfuzosin, respectively (Mathur et al.,
2015). Our system allowed us to determine the effects of
proarrhythmic drugs on the ECG-like signal generated by
CardioSlice constructs. Upon treatment with the proar-
rhythmic drug sotalol, CardioSlice constructs showed a
pathological prolongation of the QT interval, and alter-
ations in the morphology and polarity of the QRS complex
in ECG-like signals and arrhythmias, as seen in vivo (Straus
et al., 2006). Such responses were not identified in control
constructs, even though they contained the same numbers
of cardiomyocytes and fibroblasts, cultured in parallel un-
der identical conditions (except, of course, for the contin-
uous electrical stimulation applied to CardioSlice con-
structs). Because the proarrhythmic behavior of drugs is
often only found after they have been administered to
patients, we propose that the predictive capabilities of
CardioSlice constructs reflect their higher degree of close-
to-human tissue-like functionality.
In summary, the novelty of our studies is twofold. On the
one hand, we have developed a method and associated
technology for the production of thick human cardiac
macrotissues, with capabilities for electric stimulation
and on-line electrophysiological recording. On the other
hand, our findings show that continuous electrical stimula-
tion of cardiac macrotissues resulted in minor (albeit
measurable) improvements in cardiomyocyte maturation,
but greatly enhanced maturation at the tissue level.Stem Cell Reports j Vol. 13 j 207–220 j July 9, 2019 217
CardioSlice constructs showed superior electromechanical
coupling and were able to predict drug-induced cardiotox-
icity, illustrating the enhanced tissue-like functionality
achieved by our model. The physiological relevance of
CardioSlice constructs, together with their parallel and
scalable nature and the on-line electrophysiological moni-
toring feature, take our technology to the forefront of the
production of engineered human cardiac macrotissues.EXPERIMENTAL PROCEDURES
Experimental procedures are provided in detail in Supplemental
Information.
Use of Human and Animal Subjects
The use of animals for experimentation in these studies was done
following a protocol approved by the Animal Experimentation
Ethics Committee of the University of Barcelona (Barcelona,
Spain). The use of human iPSCs in this work was approved by
the Spanish competent authorities (Commission on Guarantees
concerning the Donation and Use of Human Tissues and Cells of
the Carlos III Spanish National Institute of Health).
Design, Fabrication, and Characterization of the
Perfusion Chamber and Bioreactor System
Custom-made perfusion chambers with electrical stimulation and
parallel bioreactors for continuous perfusion were designed and
fabricated as described in Supplemental Information.
Generation of Engineered Human Cardiac
Macrotissues
Cardiomyocytes were differentiated from hiPSCs (FiPS Ctrl1-
mR5F-6; cell line registered in the National Stem Cell Bank, Carlos
III Spanish National Institute of Health) as described in Supple-
mental Information, and seeded into porous collagen- and
elastin-based scaffolds of 1-mm thickness in dry conditions
(Matriderm). Detailed methods are provided in Supplemental
Information.
Morphological, Functional, and Molecular Analyses
Immunostaining, flow cytometry, qRT-PCR, confocal and electron
microscopy, contractility analyses, and electrophysiological
recording and processing of cardiac macrotissues were performed
as described in Supplemental Information.
Statistical Analyses
The number of replicatedmeasurements per experiment (n) and of
independent experiments (N) is specified in the figure legends.
Normal distribution of data was tested using the Shapiro-Wilk
and Kolmogorov-Smirnov normality tests. In the case of normal
distributions, comparisons between experiments involving two
groups were performed using Student’s t test (Figures S1A, S3B,
and S3C). Non-parametric analyses were performed using the
Mann-Whitney U test for sarcomere width (Figure 2D), fractional
area change (Figure 3C),MCR (Figure 3D), and <cos 2q> (Figure 3F),218 Stem Cell Reports j Vol. 13 j 207–220 j July 9, 2019as well as to evaluate the beating-rate change after drug treatments
(Figures 4E and 4F). Regarding the average strain per contraction
(Figure 3H) and for experiments involving more than two groups
(gene expression analysis), data were analyzed using one-way
ANOVA followed by a post hoc Tukey’s test. The difference be-
tween the variance of experimental groups inQRS duration, QT in-
terval, and QRS amplitude (Figures 4B–4D) was analyzed using
two-sample test for variances (F test), and data were normalized
to electrical pacing conditioning. Software used were Origin 8.5
(OriginLab,Northampton, USA) andGraphPad Prism6, and differ-
ences were considered significant when p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2019.05.024.
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